NeuroOne Medical Technologies
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-2.54-4.37
Price/Sales ratio
1.210.81
Earnings per Share (EPS)
$-0.31$-0.18

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-322.79-424.74-5.22-6.78-3.26-1.53-4.24-2.70-1.36-2.15-3.24-3.26
Price/Sales ratio
27.34KN/AN/AN/AN/A10.85237.17157.958.267.67422.13422.13
Price/Book Value ratio
-249.00-76.22-5.24-10.53-17.9110.116.442.812.5832.233.54-17.91
Price/Cash Flow ratio
-671.27-961.43-12.54-16.37-4.10-6.10-4.91-3.59-1.25-2.40-3.47-4.10
Price/Free Cash Flow ratio
-671.27-961.43-12.01-16.37-4.01-5.89-4.87-3.46-1.21-2.38-3.38-4.01
Price/Earnings Growth ratio
-4.3717.75-0.00-1.200.11-0.030.060.08-0.420.07-0.10-0.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%N/AN/AN/AN/A3.27%-54.87%-41.35%23.38%31.26%-518.34%3.27%
Operating Profit Margin
-4166.44%N/AN/AN/AN/A-254.45%-5735.86%-5860.15%-612.32%-344.25%-13121.66%-254.45%
Pretax Profit Margin
-4166.44%N/AN/AN/AN/A-708.00%-5584.27%-5841.95%-607.41%-356.73%-13003.81%-708.00%
Net Profit Margin
-8472.10%N/AN/AN/AN/A-708.00%-5584.27%-5841.95%-607.41%-356.73%-13003.81%-708.00%
Effective Tax Rate
-103.34%-46.49%-27.58%N/A-4.19%-55.16%-2.75%1.09%N/AN/AN/A-4.19%
Return on Assets
-3420.18%-6.31%-2023.49%-3121.25%-1273.18%-286.57%-125.31%-77.98%-146.46%-229.39%-92.38%-1273.18%
Return On Equity
77.14%17.94%100.43%155.29%547.93%-660.16%-151.79%-104.11%-189.76%-1498.52%-85.98%-85.98%
Return on Capital Employed
37.93%-40.89%84.05%89.71%469.73%-203.93%-151.22%-103.15%-189.62%-376.56%-108.17%-203.93%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A0.171.76N/AN/AN/AN/A6.710.17
Quick Ratio
0.020.850.000.000.171.766.083.703.110.905.790.17
Cash ratio
-0.020.770.000.000.141.715.842.632.960.653.490.14
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A99.0370.87N/A18.67506.91N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A130.031.06K421.30405.261.02KN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A229.061.13K421.30423.931.14KN/A
Days of Payables Outstanding
N/A1.05KN/A3.72K15.25K149.36699.621.39K167.16158.28976.68149.36
Cash Conversion Cycle
N/AN/AN/AN/AN/A-149.36-470.55-265.70254.14265.65-217.22-149.36
Debt Ratios
Debt Ratio
7.400.369.687.66N/A0.21N/AN/AN/A0.030.150.21
Debt Equity Ratio
-0.16-1.03-0.48-0.38N/A0.48N/AN/AN/A0.230.180.48
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.190.01N/A
Total Debt to Capitalization
-0.2030.65-0.92-0.61N/A0.32N/AN/AN/A0.19N/A0.32
Interest Coverage Ratio
N/AN/AN/AN/A-20.42-0.65N/AN/AN/AN/AN/A-20.42
Cash Flow to Debt Ratio
-2.21-0.07-0.87-1.68N/A-3.40N/AN/AN/A-56.64N/A-3.40
Company Equity Multiplier
-0.02-2.84-0.04-0.04-0.432.301.211.331.296.531.18-0.43
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-40.73N/AN/AN/AN/A-1.77-48.29-43.93-6.60-3.18-121.40-1.77
Free Cash Flow / Operating Cash Flow Ratio
111.0411.021.031.001.031.021.011.021.02
Cash Flow Coverage Ratio
-2.21-0.07-0.87-1.68N/A-3.40N/AN/AN/A-56.64N/A-3.40
Short Term Coverage Ratio
-2.21-0.07-0.87-1.68N/A-3.40N/AN/AN/AN/AN/A-3.40
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A